| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 149, 1695-1706, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
P Heeringa, E Brouwer, PA Klok, MG Huitema, J van den Born, JJ Weening and CG Kallenberg
Department of Clinical Immunology, University Hospital Groningen, The Netherlands.
Autoantibodies to myeloperoxidase (MPO) are present in sera from patients with various forms of vasculitis-associated glomerulonephritis. Evidence for a pathogenic role of anti-MPO antibodies has been provided mainly by in vitro studies. We studied the pathogenic role of autoantibodies to MPO in a rat model of mild immune- mediated glomerular injury. Brown Norway rats were immunized with human MPO in complete Freund's adjuvant or with complete Freund's adjuvant alone. At 2 weeks after immunization, rats had developed antibodies to human and rat MPO as detected by indirect immunofluorescence, enzyme- linked immunosorbent assay, and immunoprecipitation. At this time point, rats were intravenously injected with a subnephritogenic dose of 150 micrograms of rabbit anti-rat GBM. Rats were sacrificed at 4 hours, 24 hours, 4 days, and 10 days after antibody administration. Control immunized rats developed mild glomerulonephritis characterized by slight proteinuria at day 10 (14.8 +/- 8.1 mg/24 hours) and moderate intraglomerular accumulation of ED1+ macrophages. Crescent formation, tuft necrosis, and tubular atrophy were not observed in those rats. In contrast, rats immunized with MPO developed severe glomerulonephritis characterized by the early occurrence of severe hematuria, marked proteinuria at day 10 (76.2 +/- 18.2 mg/24 hours), and massive glomerular deposition of fibrin. Complement and rat IgG were present in insudative lesions, but no linear pattern along the glomerular capillary wall was observed. By light microscopy, severe glomerular lesions were found at day 10 consisting of crescent formation and fibrinoid necrosis of capillary loops. In the interstitium, tubular necrosis and atrophy and marked interstitial mononuclear infiltration were found in conclusion, autoantibodies to MPO severely aggravate subclinical anti-GBM disease demonstrating their in vivo pathogenic potential.
This article has been cited by other articles:
 |
|
 |
|
  D. O. Bunch, J. S. Silver, M. C. Majure, P. Sullivan, D. A. Alcorta, H. Chin, S. L. Hogan, Y. I. Lindstrom, S. H. Clarke, R. J. Falk, et al. Maintenance of Tolerance by Regulation of Anti-myeloperoxidase B Cells J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1763 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J L Gallagher, S Sinha, R Reeve, and P A Kalra Importance of checking anti-glomerular basement membrane antibody status in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis Postgrad. Med. J., April 1, 2008; 84(990): 220 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yang, T. Hellmark, J. Zhao, Z. Cui, M. Segelmark, M.-h. Zhao, and H.-y. Wang Antigen and Epitope Specificity of Anti-Glomerular Basement Membrane Antibodies in Patients with Goodpasture Disease with or without Anti-Neutrophil Cytoplasmic Antibodies J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1338 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-J. Ruth, A. R. Kitching, R. Y.Q. Kwan, D. Odobasic, J. D.K. Ooi, J. R. Timoshanko, M. J. Hickey, and S. R. Holdsworth Anti-Neutrophil Cytoplasmic Antibodies and Effector CD4+ Cells Play Nonredundant Roles in Anti-Myeloperoxidase Crescentic Glomerulonephritis J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1940 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Watts, L. Harper, D. Jayne, J. Levy, C. Pusey, C. Savage, D. G. I. Scott, and J. Williams Translational research in autoimmunity: aims of therapy in vasculitis Rheumatology, May 1, 2005; 44(5): 573 - 576. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Pfister, M. Ollert, L. F. Frohlich, L. Quintanilla-Martinez, T. V. Colby, U. Specks, and D. E. Jenne Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo Blood, September 1, 2004; 104(5): 1411 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Rarok, P. C. Limburg, and C. G. M. Kallenberg Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies J. Leukoc. Biol., July 1, 2003; 74(1): 3 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Falk and J. C. Jennette ANCA Are Pathogenic--Oh Yes They Are! J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1977 - 1979. [Full Text] [PDF]
|
|
|
|
 |
|
 R H Brons, M C J M de Jong, N K de Boer, C A Stegeman, C G M Kallenberg, and J W C. Tervaert Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis Ann Rheum Dis, December 1, 2001; 60(12): 1097 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. PATRY, D. C. TREWICK, M. GREGOIRE, M. A. P. AUDRAIN, A. M. N. MOREAU, J.-Y. MULLER, K. MEFLAH, and V. L. M. ESNAULT Rats Injected with Syngenic Rat Apoptotic Neutrophils Develop Antineutrophil Cytoplasmic Antibodies J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1764 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. SCHNABEL, E. CSERNOK, J. BRAUN, and W. L. GROSS Activation of Neutrophils, Eosinophils, and Lymphocytes in the Lower Respiratory Tract in Wegener's Granulomatosis Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 399 - 405. [Abstract] [Full Text]
|
|
|
|
|
|
P. FOUCHER, P. HEERINGA, A. H. PETERSEN, M. G. HUITEMA, E. BROUWER, J. W. COHEN TERVAERT, J. PROP, P. CAMUS, J. J. WEENING, and C. G. M. KALLENBERG Antimyeloperoxidase-associated Lung Disease . An Experimental Model Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 987 - 994. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. CUNNINGHAM, X. R. HUANG, J. P. DOWLING, P. G. TIPPING, and S. R. HOLDSWORTH Prominence of Cell-Mediated Immunity Effectors in "Pauci-Immune" Glomerulonephritis J. Am. Soc. Nephrol., March 1, 1999; 10(3): 499 - 506. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
